Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus
empagliflozin
1245.48
NCT01370005
Diabetes Mellitus, Type 2; Hypertension
Phase 3
 
December 2014

Powered by ideaPoint, Inc.